Pharmacotherapy of suicidal ideation and behaviour

The International Handbook of Suicide and Attempted Suicide

Volumn , Issue , 2008, Pages 487-502

  Verkes, Robbert J ^a   Cowen, Philip J ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Mood disorders; Pharmacotherapy; Psychiatric disorders; Psychotropic drug treatment; Schizophrenia

Indexed keywords

EID: 84949796626     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470698976.ch27     Document Type: Chapter

References (59)

1. Ahrens, B. and Linden, M. (1996) Is there a suicidality syndrome independent of specific major psychiatric disorder? Results of a split-half multiple regression analysis. Acta Psychiatrica Scandinavica, 94: 79-86.
2. Allgulander, C. (1994) Suicide and mortality patterns in anxiety neurosis and depressive neurosis. Archives of General Psychiatry, 51: 708-712.
3. Allgulander, C. and Näsman, P. (1991) Regular hypnotic drug treatment in a sample of 32,679 Swedes: associations with somatic and mental health, inpatient psychiatric diagnoses and suicide, derived with automatic record-linkage. Psychosomatic Medicine, 53:101-108.
4. Beasley, C.M., Dornseif, B.E., Bosomworth, J.C., Sayer, M.E., Rampey, A.H., Heiligenstein, J.H., Thompson, V.L., Murphy, D.J. and Masica, D.N. (1991) Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression. British Medical Journal, 303: 685-692.
5. Beasley, C.M., Potvin, J.H., Masica, D.N.,Wheadon, D.E., Dornseif, B.E. and Genduso, L.A. (1992) Fluoxetine: no association with suicidality in obsessive-compulsive disorder. Journal of Affective Disorders, 24:1-10.
6. Bond, A.J., Curran, H.V., Bruce, M.S., O'Sullivan, G. and Shine, P. (1995) Behavioral aggression in panic disorder after 8 weeks' treatment with alprazolam. Journal of Affective Disorders, 35:117-123.
7. Coccaro, E.F. and Kavoussi, R.J. (1997) Fluoxetine and impulsive aggressive behavior in personality-disordered subjects. Archives of General Psychiatry, 54:1081-1088.
8. Coppen, A., Standish-Barry, H., Bailey, J., Houston, G., Silcocks, P. and Hermon, C. (1991) Does lithium reduce mortality of recurrent mood disorders? Journal of Affective Disorders, 23:1-7.
9. Cowdry, R.W. and Gardner, D.L. (1998) Alprazolam, carbamazepine, trifluoperazine, and tranylcypromine. Archives of General Psychiatry, 45:111-119.
10. Cowen, P.J. (1996) Pharmacotherapy for anxiety disorders: drugs available. Advances in Psychiatric Treatment, 3:66-71.
11. Fawcett, J., Scheftner, W.A., Fogg, L., Clark, D.C, Young, M.A., Hedeker, D. and Gibbons, R. (1990) Time-related predictors of suicide in major affective disorder. American Journal of Psychiatry, 151:1189-1194.
12. Fawcett, J. (1995) The detection and consequences of anxiety in clinical depression. Journal of Clinical Psychiatry, 58 (Suppl. 8): 35-40.
13. Henry, J.A. (1997) Epidemiology and relative toxicity of antidepressant drugs in overdose. Drug Safety, 16: 374-390.
14. Hirsch, S.R., Walsh, C. and Draper, R. (1983) The concept and efficacy of the treatment of parasuicide. British Journal of Clinical Pharmacology, 15:189-194S.
15. Isacsson, G., Bergman, U. and Rich, C.L. (1996) Epidemiological data suggest antide-pressants reduce suicide risk among depressives. Journal of Affective Disorders, 41: 1-8.
16. Jick, S.S., Dean, A.D. and Jick, H. (1995) Antidepressants and suicide. British Medical Journal, 310:215-218.
17. Jonas, J.M. and Hearron, A.E. (1996) Alprazolam and suicidal ideation: a meta-analysis of controlled trials in the treatment of depression. Journal of Clinical Psychopharma-cology, 16: 208-211.
18. Jones, J.S., Stein, D.J., Stanley, B., Guido, J.R., Winchel, R. and Stanley, M. (1994) Nega-tive and depressive symptoms in suicidal schizophrenics. Acta Psychiatrica Scandinav-ica, 89: 81-87.
19. Kavoussi, R.J., Liu, J. and Coccaro, E.F. (1994) An open trial of sertraline in personality disordered patients with impulsive aggression. Journal of Clinical Psychiatry, 55:137-141.
20. Kutcher, S., Papatheodorou, G., Reiter, S. and Gardner, D. (1995) The successful phar-macological treatment of adolescents and young adults with borderline personality dis-order: a preliminary open trial of flupenthixol. Journal of Psychiatry and Neuroscience, 20:113-118.
21. Letizia, C, Kapik, B. and Flanders, W.D. (1996) Suicidal risk during controlled clinical investigations of fiuvoxamine. Journal of Clinical Psychiatry, 57:415-421.
22. Links, P.S., Steiner, M., Boiago,I. and Irwin D. (1990) Lithium therapy for borderline patients: preliminary findings. Journal of Personality Disorder, 4:173-181.
23. Mann, J.J. and Kapur, S. (1991) The emergence of suicidal ideation and behavior during antidepressant pharmacotherapy. Archives of General Psychiatry, 48:1027-1033.
24. Markovitz, P.J., Calabrese, J.R., Schultz, S.C and Meltzer, H.Y. (1991) Fluoxetine in the treatment of borderline and schizotypal presonality disorders. American Journal of Psychiatry, 148:1064-1067.
25. Meltzer, H.Y. (1997) Treatment-resistant schizophrenia-the role of clozapine. Current Medical Research Opinion, 14:1-20.
26. Meltzer, H.Y. and Okayli, G. (1995) Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk-benefit assessment. American Journal of Psychiatry, 152:183-190.
27. Modestin, J. and Schwarzenbach, F. (1992) Effect of psychopharmacotherapy on suicide risk in discharged psychiatric inpatients. Acta Psychiatrica Scandinavica, 85: 173-175.
28. Montgomery, D.B., Roberts, A., Green, M., Bullock,T., Baldwin, D. and Montgomery, S.A. (1994) Lack of efficacy of fluoxetine in recurrent brief depression and suicidal attempts. European Archives of Psychiatry and Clinical Neurological Sciences, 244: 211-215.
29. Montgomery, S.A. and Montgomery, D.B. (1982) Pharmacological prevention of suicidal behaviour. Journal of Affective Disorders, 4: 291-298.
30. Montgomery, S.A., Roy, D. and Montgomery, D.B. (1983) The prevention of recurrent suicidal acts. British Journal of Clinical Pharmacology, 15:183-188S.
31. Montgomery, S.A., Dunner, D.L. and Dunbar, G.C. (1995) Reduction of suicidal thoughts with paroxetine in comparison with reference antidepressants and placebo. European Neuropsychopharmocology, 5: 5-13.
32. Müller-Oerlinghausen, B., Müser-Causemann, B. and Volk, J. (1992) Suicides and parasuicides in a high-risk patient group on and off lithium long-term medication. Journal of Affective Disorders, 25,261-270.
33. Neutel, C.I. and Patten, S.B. (1997) Risk of suicide attempts after benzodiazepine and/or antidepressant use. Annals of Epidemiology, 7: 568-574.
34. Norden, M.J. (1989) Fluoxetine in borderline personality disorder. Progress in Neu-ropsychopharmacology and Biological Psychiatry, 13: 885-893.
35. Nutt, D. (1997) Management of patients with depression associated with anxiety symptoms. Journal of Clinical Psychiatry, 58 (Suppl. 8): 11-16.
36. O'Sullivan, G.H., Noshirvani, H., Basoglu, M., Marks, I., Swinson, R., Kuch, K. and Kirby, M. (1994) Safety and side-effects of alprazolam: controlled study in agoraphobia with panic disorder. British Journal of Psychiatry, 165: 79-86.
37. Ottevanger, E.A. (1991) Fluvoxamine activity profile with special emphasis on the effect on suicidal ideation. European Journal of Clinical Research, 1: 47-54.
38. Power, A.C. and Cowen, P.J. (1992) Fluoxetine and suicidal behaviour: some clinical and theoretical aspects of a controversy. British Journal of Psychiatry, 161: 735-741.
39. Praschak-Rieder, N., Neumeister, A., Hesselmann, B., Willeit, M., Barnas, C. and Kasper, S. (1997) Suicidal tendencies as a complication of light therapy for seasonal affective disorder: a report of three cases. Journal of Clinical Psychiatry, 58: 389-392.
40. Rouillon, E, Phillips, R., Serrurier, D., Ansart, E. and Gerard, M.J. (1989) Prophylactic efficacy of maprotiline on relapses of unipolar depression. Encephale (Paris), 15: 527-534.
41. Rubey, R.N., Johnson, M.R., Emmanuel, N., Lydiard, R.B. (1996) Fluoxetine in the treatment of anger: an open clinical trial. Journal of Clinical Psychiatry, 57: 398-101.
42. Salzman, C, Wolfson, A.N., Schatzberg, A., Looper, J., Henke, R., Albanese, M., Swartz, J. and Miyawaki, E. (1995) Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder. Journal of Clinical Psychopharmacology, 15: 23-29.
43. Sheard, M.H., Marini, J.L., Bridges, C.I. and Wagner, E. (1976) The effect of lithium on impulsive aggressive behavior in man. American Journal of Psychiatry, 133: 1409-1413.
44. Siris, S.G., Bermanzohn, P.C., Gonzalez, A., Mason, S.E., White, C.V. and Shuwall, M.A. (1991) Use of antidepressants for negative symptoms in a subset of schizophrenic patients. Psychopharmacology Bulletin, 27: 331-335.
45. Soloff, P.H., George, A., Nathan, R.S., Schulz, P.M. and Perel, J.M. (1986) Paradoxical effects of amitriptyline on borderline patients. American Journal of Psychiatry, 143: 1603-1605.
46. Soloff, P.H., George, A., Nathan, R.S., Schulz, P.M., Cornelius, J.R., Herring, J. and Perel, J.M. (1989) Amitriptyline versus haloperidol in borderlines: final outcomes and predictors of response. Journal of Clinical Psychopharmacology, 9: 246.
47. Soloff, P.H., Cornelius, X, George, A., Nathan, S., Perel, J.M. and Ulrich, R.F. (1993) Effi-cacy of phenelzine and haloperidol in borderline personality disorder. Archives of General Psychiatry, 50: 377-385.
48. Stein, D.J., Simeon, D., Frenkel, M., Islam, M.N. and Hollander, E. (1995) An open trial of valproate in borderline personality disorder. Journal of Clinical Psychiatry, 56: 506-510.
49. Thies-Flechtner, K., Müller-Oerlinghausen, B., Seibert, W., Walther, A. and Greil, W. (1996) Effect of prophylactic treatment on suicide risk in patients with major affective disorders. Pharmacopsychiatry, 29:103-107.
50. Tollefson, G.D., Sanger, T.M., Lu, Y. and Thieme, M.E. (1998) Depressive signs and symptoms in schizophrenia-a prospective blinded trial of olanzepine versus haloperi-dol. Archives of General Psychiatry, 55: 250-258.
51. Tondo, L., Jamison, K.R. and Baldessarini, R.J. (1997) Effect of lithium maintenance on suicidal behavior in major mood disorders. Annals of New York Academy of Science, 836: 340-351.
52. Tondo, L., Baldessarini, R.J., Hennen, J., Floris, G., Silvetti, F. and Tohen, M. (1998) Lithium treatment and risk of suicidal behavior in bipolar disorder patients. Journal of Clinical Psychiatry, 59:405-414.
53. Tran, P.V., Hamilton, S.H., Kuntz, A.J., Potvin, J.H., Andersen, S.W., Beasley, C. and Tollefson, G.D. (1997) Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders. Journal of Clinical Psychopharmacology, 17:407-418.
54. Verkes, R.J., Fekkes, D., Zwinderman, A.H., Hengeveld, M.W., Van der Mast, R.C., Tuyl, J.P., Kerkhof, A.J.F.M. and Van Kempen, G.M.J. (1997) Platelet serotonin and [3H]paroxetine binding correlate with recurrence of suicidal behavior. Psychophar-macology, 132: 89-94.
55. Verkes, R.J., Van der Mast, R.C., Hengeveld, M.W., Tuyl, J.P., Zwinderman, A.H. and Van Kempen, G.M.J. (1998) Reduction by paroxetine of suicidal behavior in patients with repeated suicide attempts but not major depression. American Journal of Psychiatry, 155: 543-547.
56. Walker, A.M., Lanza, L.L., Arellano, F. and Rothman, K.J. (1997) Mortality in current and former users of clozapine. Epidemiology, 8:1181-1185. Warshaw, M.G. and Keller, M.B. (1996) The relationship between fluoxetine use and suicidal behavior in 654 subjects with anxiety disorders. Journal of Clinical Psychiatry, 57:158-166.
57. Warshaw, M.G. and Keller, M.B. (1996) The relationship between fluoxetine use and suicidal behavior in 654 subjects with anxiety disorders. Journal of Clinical Psychiatry, 57: 158-166.
58. Wheadon, D.E., Rampey, A.H., Thompson, V.L., Potvin, J.H., Masica, D.N., Beasley, CM. (1992) Lack of association between fluoxetine and suicidality in bulimia nervosa. Journal of Clinical Psychiatry, 53:235-241.
59. Wilcox, J.A. (1995) Divalproex sodium as a treatment for borderline personality dis-order. Annals of Clinical Psychiatry, 7: 33-37.